174 related articles for article (PubMed ID: 30654192)
1. Efficient Knockdown and Lack of Passenger Strand Activity by Dicer-Independent shRNAs Expressed from Pol II-Driven MicroRNA Scaffolds.
Kaadt E; Alsing S; Cecchi CR; Damgaard CK; Corydon TJ; Aagaard L
Mol Ther Nucleic Acids; 2019 Mar; 14():318-328. PubMed ID: 30654192
[TBL] [Abstract][Full Text] [Related]
2.
Alsing S; Doktor TK; Askou AL; Jensen EG; Ahmadov U; Kristensen LS; Andresen BS; Aagaard L; Corydon TJ
Mol Ther Nucleic Acids; 2022 Jun; 28():58-76. PubMed ID: 35356684
[TBL] [Abstract][Full Text] [Related]
3. Towards Antiviral shRNAs Based on the AgoshRNA Design.
Liu YP; Karg M; Herrera-Carrillo E; Berkhout B
PLoS One; 2015; 10(6):e0128618. PubMed ID: 26087209
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic insights on the Dicer-independent AGO2-mediated processing of AgoshRNAs.
Liu YP; Karg M; Harwig A; Herrera-Carrillo E; Jongejan A; van Kampen A; Berkhout B
RNA Biol; 2015; 12(1):92-100. PubMed ID: 25826416
[TBL] [Abstract][Full Text] [Related]
5. Silencing of HIV-1 by AgoshRNA molecules.
Herrera-Carrillo E; Harwig A; Berkhout B
Gene Ther; 2017 Aug; 24(8):453-461. PubMed ID: 28553929
[TBL] [Abstract][Full Text] [Related]
6. miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction.
Guda S; Brendel C; Renella R; Du P; Bauer DE; Canver MC; Grenier JK; Grimson AW; Kamran SC; Thornton J; de Boer H; Root DE; Milsom MD; Orkin SH; Gregory RI; Williams DA
Mol Ther; 2015 Sep; 23(9):1465-74. PubMed ID: 26080908
[TBL] [Abstract][Full Text] [Related]
7. Influence of a 3' Terminal Ribozyme on AgoshRNA Biogenesis and Activity.
Herrera-Carrillo E; Gao Z; Berkhout B
Mol Ther Nucleic Acids; 2019 Jun; 16():452-462. PubMed ID: 31048184
[TBL] [Abstract][Full Text] [Related]
8. Optimization and comparison of knockdown efficacy between polymerase II expressed shRNA and artificial miRNA targeting luciferase and Apolipoprotein B100.
Maczuga P; Koornneef A; Borel F; Petry H; van Deventer S; Ritsema T; Konstantinova P
BMC Biotechnol; 2012 Jul; 12():42. PubMed ID: 22827812
[TBL] [Abstract][Full Text] [Related]
9. Boosting AgoshRNA activity by optimized 5'-terminal nucleotide selection.
Gao Z; Berkhout B; Herrera-Carrillo E
RNA Biol; 2019 Jul; 16(7):890-898. PubMed ID: 30991896
[TBL] [Abstract][Full Text] [Related]
10. Toward optimization of AgoshRNA molecules that use a non-canonical RNAi pathway: variations in the top and bottom base pairs.
Herrera-Carrillo E; Harwig A; Berkhout B
RNA Biol; 2015; 12(4):447-56. PubMed ID: 25747107
[TBL] [Abstract][Full Text] [Related]
11. siRNA release from pri-miRNA scaffolds is controlled by the sequence and structure of RNA.
Galka-Marciniak P; Olejniczak M; Starega-Roslan J; Szczesniak MW; Makalowska I; Krzyzosiak WJ
Biochim Biophys Acta; 2016 Apr; 1859(4):639-49. PubMed ID: 26921501
[TBL] [Abstract][Full Text] [Related]
12. Analysis of AgoshRNA maturation and loading into Ago2.
Harwig A; Kruize Z; Yang Z; Restle T; Berkhout B
PLoS One; 2017; 12(8):e0183269. PubMed ID: 28809941
[TBL] [Abstract][Full Text] [Related]
13. Design and Evaluation of AgoshRNAs with 3'-Terminal HDV Ribozymes to Enhance the Silencing Activity.
Berkhout B; Herrera-Carrillo E
Methods Mol Biol; 2021; 2167():225-252. PubMed ID: 32712923
[TBL] [Abstract][Full Text] [Related]
14. Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis.
Kim YK; Kim B; Kim VN
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1881-9. PubMed ID: 26976605
[TBL] [Abstract][Full Text] [Related]
15. Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo.
Ely A; Naidoo T; Mufamadi S; Crowther C; Arbuthnot P
Mol Ther; 2008 Jun; 16(6):1105-12. PubMed ID: 18431360
[TBL] [Abstract][Full Text] [Related]
16. Deep Sequence Analysis of AgoshRNA Processing Reveals 3' A Addition and Trimming.
Harwig A; Herrera-Carrillo E; Jongejan A; van Kampen AH; Berkhout B
Mol Ther Nucleic Acids; 2015 Jul; 4(7):e247. PubMed ID: 26172504
[TBL] [Abstract][Full Text] [Related]
17. Optimization of a microRNA expression vector for function analysis of microRNA.
Furukawa N; Sakurai F; Katayama K; Seki N; Kawabata K; Mizuguchi H
J Control Release; 2011 Feb; 150(1):94-101. PubMed ID: 21146569
[TBL] [Abstract][Full Text] [Related]
18. Influence of the loop size and nucleotide composition on AgoshRNA biogenesis and activity.
Herrera-Carrillo E; Harwig A; Berkhout B
RNA Biol; 2017 Nov; 14(11):1559-1569. PubMed ID: 28569591
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, accumulation, and transcriptional profile of anti-HIV shRNAs expressed from human U6, 7SK, and H1 promoters.
Goguen RP; Del Corpo O; Malard CMG; Daher A; Alpuche-Lazcano SP; Chen MJ; Scarborough RJ; Gatignol A
Mol Ther Nucleic Acids; 2021 Mar; 23():1020-1034. PubMed ID: 33614248
[TBL] [Abstract][Full Text] [Related]
20. Short Hairpin RNAs for Strand-Specific Small Interfering RNA Production.
Sheng P; Flood KA; Xie M
Front Bioeng Biotechnol; 2020; 8():940. PubMed ID: 32850763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
